Public-Private Partnerships in the Wake of COVID-19

As the outbreak of COVID-19, a disease caused by a novel strain of coronavirus, evolves around the world, the public and private sectors are diligently working together to find solutions.

New Report: Clinical Research Drives Health Innovation

Southeast Asia is home to nearly 9 percent of the world’s population and one of the fastest growing economic regions in the world. Thanks to treatment breakthroughs and wider health care access, people across the region are living longer than ever before. There is tremendous opportunity to build on this foundation through additional investment in early stage clinical research and pro-innovation policy reforms that continue to improve the health for those living in Southeast Asia.

Healthy Innovation Statement on COVID-19

Our thoughts are with those affected by the outbreak of COVID-19, the novel strain of the coronavirus, both here in Southeast Asia and around the globe.

EU Commission Cites Systemic IP Barriers in Southeast Asia

Strong intellectual property (IP) protection and enforcement is critical to helping countries attract foreign investment, promote economic growth, provide greater access to medicines and improve patient outcomes. The biennial “Report on the Protection and Enforcement of Intellectual Property Rights in Third Countries” cites Malaysia, Indonesia and Thailand as priority countries that will need to strengthen their IP regulations to stay globally competitive.